Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Tadmor

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|May 24, 2011
Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopyAaron Polliack, Tamar Tadmor
Leukemia & Lymphoma|May 24, 2011
Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemiaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|June 11, 2011
Mantle cell lymphoma: curcumin nanodisks and possible new concepts on drug delivery for an incurable lymphomaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|September 21, 2010
Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide?Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|February 15, 2011
Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|November 18, 2011
Absolute monocyte count identifies high-risk patients with lymphomas: "absolutely" simple and "counts" mean a lot!Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|February 17, 2012
Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma--revisiting "the super- family " sagaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|August 23, 2011
Rituximab in space: intrapleural and other novel routes of administration for lymphomas and lymphoid leukemiasTamar Tadmor, Aaron Polliack
Best Practice & Research. Clinical Haematology|November 29, 2015
Hairy cell leukemia: Uncommon clinical features, unusual sites of involvement and some rare associationsTamar Tadmor, Aaron Polliack
Cancers|October 23, 2021
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel AgentsTamar Tadmor, Ilana Levy
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|May 24, 2011
Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopyAaron Polliack, Tamar Tadmor
Leukemia & Lymphoma|May 24, 2011
Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemiaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|June 11, 2011
Mantle cell lymphoma: curcumin nanodisks and possible new concepts on drug delivery for an incurable lymphomaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|September 21, 2010
Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide?Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|February 15, 2011
Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|November 18, 2011
Absolute monocyte count identifies high-risk patients with lymphomas: "absolutely" simple and "counts" mean a lot!Tamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|February 17, 2012
Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma--revisiting "the super- family " sagaTamar Tadmor, Aaron Polliack
Leukemia & Lymphoma|August 23, 2011
Rituximab in space: intrapleural and other novel routes of administration for lymphomas and lymphoid leukemiasTamar Tadmor, Aaron Polliack
Best Practice & Research. Clinical Haematology|November 29, 2015
Hairy cell leukemia: Uncommon clinical features, unusual sites of involvement and some rare associationsTamar Tadmor, Aaron Polliack
Cancers|October 23, 2021
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel AgentsTamar Tadmor, Ilana Levy
Pageof 22